Form EFFECT LIGHTPATH TECHNOLOGIES
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 23, 2026 |
| Accession Number: | 0001437749-26-024149 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Two Rides Across Guangxi, Chasing Wind Amid Mountains and Rivers | 2026 Cotti Coffee Tour of Guangxi Mass Race·Ride Across Guangxi Series Concludes Successfully
- Advanced Cervical Cancer Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
- Atopic Dermatitis Pipeline Landscape 2026: Late-Stage Candidates, MOA Trends, and Routes of Administration by DelveInsight | GSk, Nestle SA, Pfizer, Regeneron, Abbvie, Allergan, Bausch Health Company
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
